Cite
MLA Citation
P Nash et al.. “OP0201 A phase 3 study of the efficacy and safety of ixekizumab in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitor(s).” Annals of the rheumatic diseases, vol. 76, n.d., p. 135. http://access.bl.uk/ark:/81055/vdc_100135145465.0x000063